Comment in

• Authors' reply to Foster and colleagues.

  Koretz RL, Lin KW, Ioannidis JP, Lenzer J. Koretz RL, et al. BMJ. 2015 Feb 24;350:h1000. doi: 10.1136/bmj.h1000. BMJ. 2015. PMID: 25711887 No abstract available.
• Early diagnosis and treatment: the goal of hepatitis C screening.

  Selvapatt N, Brown A, Thursz M. Selvapatt N, et al. BMJ. 2015 Feb 24;350:h635. doi: 10.1136/bmj.h635. BMJ. 2015. PMID: 25711892 No abstract available.
• NICE's recommendation on sofosbuvir for hepatitis C.

  Badrinath P. Badrinath P. BMJ. 2015 Feb 24;350:h637. doi: 10.1136/bmj.h637. BMJ. 2015. PMID: 25711893 No abstract available.
• Hepatitis C screening of men who have sex with men.

  Ward CJ, Lee V. Ward CJ, et al. BMJ. 2015 Feb 24;350:h642. doi: 10.1136/bmj.h642. BMJ. 2015. PMID: 25711894 No abstract available.
• Screening and treatment for hepatitis C: a balanced perspective.

  Matthews PC, Jeffery K, Klenerman P, Barnes E, Cooke G. Matthews PC, et al. BMJ. 2015 Feb 24;350:h644. doi: 10.1136/bmj.h644. BMJ. 2015. PMID: 25711895 No abstract available.
• Authors' reply to Selvapatt and colleagues, Matthews and colleagues, Badrinath, and Ward and Lee.

  Koretz RL, Lin KW, Ioannidis JP, Lenzer J. Koretz RL, et al. BMJ. 2015 Feb 24;350:h674. doi: 10.1136/bmj.h674. BMJ. 2015. PMID: 25711896 No abstract available.
• Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified.

  Foster GR, Gore C, Hudson M, Moss P, Ustianowski A, Ryder S, Bhagani S. Foster GR, et al. BMJ. 2015 Feb 24;350:h998. doi: 10.1136/bmj.h998. BMJ. 2015. PMID: 25711900 No abstract available.